Guaifenesin and Dextromethorphan HBR 30 mg/1

Guaifenesin and Dextromethorphan HBR · TABLET, EXTENDED RELEASE · Dr. Reddy's Laboratories Inc.

No Recall History

Plain English

Guaifenesin and Dextromethorphan HBR is a tablet, extended release containing guaifenesin and dextromethorphan hbr at 30 mg/1, taken oral. Manufactured by Dr. Reddy's Laboratories Inc..

Key Facts

Brand Name: Guaifenesin and Dextromethorphan HBR
Generic Name: Guaifenesin and Dextromethorphan HBR
NDC Code (Product): 43598-231
Manufacturer: Dr. Reddy's Laboratories Inc.
Strength: 30 mg/1
Dosage Form: TABLET, EXTENDED RELEASE
Route: ORAL
Marketing Status
Application #: ANDA217340
Drug Class: Expectorant [EPC]
Marketing Start: 08/15/2023

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dehydration3 reports

renal failure acute3 reports

anaemia2 reports

cardio-respiratory arrest2 reports

chronic obstructive pulmonary disease2 reports

colitis2 reports

completed suicide2 reports

convulsion2 reports

deep vein thrombosis2 reports

dyspnoea2 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves: cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the intensity of coughing the impulse to cough to help you get to sleep

Dosage & Administration

Directions do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for timing of meals adults and children 12 years and older: 1 or 2 tablets every 12 hours; not more than 4 tablets in 24 hours children under 12 years of age: do not use

Warnings

Warnings Do not use for children under 12 years of age if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Frequently Asked Questions

What is Guaifenesin and Dextromethorphan HBR used for?

Guaifenesin and Dextromethorphan HBR contains Guaifenesin and Dextromethorphan HBR. It is a tablet, extended release taken oral. Consult your doctor for specific uses.

Is Guaifenesin and Dextromethorphan HBR a controlled substance?

Guaifenesin and Dextromethorphan HBR is not classified as a controlled substance by the DEA.

What is the generic name for Guaifenesin and Dextromethorphan HBR?

The generic name for Guaifenesin and Dextromethorphan HBR is Guaifenesin and Dextromethorphan HBR. There are 12 other brand versions of Guaifenesin and Dextromethorphan HBR.

What is the NDC code for Guaifenesin and Dextromethorphan HBR 30 mg/1?

The NDC (National Drug Code) for Guaifenesin and Dextromethorphan HBR 30 mg/1 is 43598-231, listed by Dr. Reddy's Laboratories Inc..

Product NDC

43598-231

Package NDC

43598-231-01

Other Guaifenesin Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)